Profilo
Keith B. Nolop worked as a Senior Director at Schering-Plough Corp.
and as a Vice President-Clinical Research at CoTherix, Inc. He was also the Chief Medical Officer & SVP-Development at Plexxikon, Inc. In 2013-2014, he served as the Chief Medical Officer at Kite Pharma, Inc. Nolop holds a doctorate degree from Vanderbilt University.
Precedenti posizioni note di Keith B. Nolop
| Società | Posizione | Fine |
|---|---|---|
| KITE PHARMA INC | Direttore Tecnico/Scientifico/R&S | 01/05/2014 |
CoTherix, Inc.
CoTherix, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic products | Direttore Tecnico/Scientifico/R&S | - |
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical & health care products | Direttore/Membro del Consiglio | 25/05/2010 |
Plexxikon, Inc.
Plexxikon, Inc. Miscellaneous Commercial ServicesCommercial Services Provides clinical and medical drug discovery and development services | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Keith B. Nolop
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical & health care products | Health Technology |
CoTherix, Inc.
CoTherix, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic products | Health Technology |
Plexxikon, Inc.
Plexxikon, Inc. Miscellaneous Commercial ServicesCommercial Services Provides clinical and medical drug discovery and development services | Commercial Services |
Vanderbilt University
Vanderbilt University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kite Pharma, Inc.
Kite Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biotechnology company which engages in the development of novel cancer immunotherapeutic products | Health Technology |
















